Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91)
NASDAQ:0K91
Earnings Data
Report Date
Aug 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.37Last Year’s EPS
-2.78Same Quarter Last Year
Based on 0 Analysts Ratings
DE:0K91 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:0K91 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | €4.38 | €4.31 | -1.55% |
Mar 27, 2026 | €3.26 | €3.16 | -3.07% |
Nov 06, 2025 | €7.25 | €6.65 | -8.28% |
Aug 06, 2025 | €20.40 | €22.20 | +8.82% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91) report earnings?
Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91) is schdueled to report earning on Aug 06, 2026, Before Open (Confirmed).
What is Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91) earnings time?
Quantum Biopharma Ltd. Subordinate Voting Shares Class B (DE:0K91) earnings time is at Aug 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Quantum Biopharma Ltd. Subordinate Voting Shares Class B stock?
The P/E ratio of Quantum Biopharma is N/A.
What is DE:0K91 EPS forecast?
DE:0K91 EPS forecast for the fiscal quarter 2026 (Q2) is -0.37.